Chronic kidney disease and dialysis in Mexico

被引:0
|
作者
Paniagua, Ramon
Ramos, Alfonso
Fabian, Rosaura
Lagunas, Jesus
Amato, Dante
机构
[1] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo 21, Unidad Invest Med Enfermedades Nefrol, Col Doctores Mexico, DF, Mexico
[2] Hosp Gen Zona 1 Hermosillo, Hermosillo, Sonora, Mexico
[3] UMAE Hosp Gen Gaudencio Gonzalez Garza, Mexico City, DF, Mexico
[4] Inst Mexicano Seguro Social, Mexico City, DF, Mexico
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2007年 / 27卷 / 04期
关键词
chronic kidney disease; mexico;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The increasing rates in incidence and prevalence of chronic kidney disease (CKD) are important challenges for health systems around the world, and are even more significant for undeveloped countries. In Mexico the prevalence of CKD seems to be similar to that in highly developed nations, with diabetes as the leading cause of CKD; however, human and economic resources seem to be insufficient for treatment needs. This is reflected in the unacceptably high mortality rates and in noncompliance with established standards and guidelines. Several measures need to be taken to improve this picture, such as more efficient programs for the prevention of obesity, diabetes, and hypertension. Organizing a national registry of patients with CKD is now a pressing need, as is a continuous search for additional funding and budgets to increase the number of qualified nephrotogists and specialized nurses and to continue the much-needed research on CKD.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 50 条
  • [31] Aldosterone antagonists for people with chronic kidney disease requiring dialysis
    Hasegawa, Takeshi
    Nishiwaki, Hiroki
    Ota, Erika
    Levack, William M. M.
    Noma, Hisashi
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [32] Congestive heart failure in patients with chronic kidney disease and on dialysis
    Schreiber, BD
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 179 - 193
  • [33] Iron deficiency in non-dialysis chronic kidney disease
    Fishbane, Steven
    Singh, Ajay K.
    KIDNEY INTERNATIONAL, 2009, 75 (07) : 752 - 754
  • [34] Help patients with chronic kidney disease stave off dialysis
    Linden, Ariel
    Biuso, Thomas J.
    Butterworth, Susan W.
    JOURNAL OF FAMILY PRACTICE, 2010, 59 (04): : 213 - 219
  • [35] Depression in patients with chronic kidney disease on dialysis in Saudi Arabia
    Faten Al Zaben
    Doaa Ahmed Khalifa
    Mohammad Gamal Sehlo
    Saad Al Shohaib
    Faisul Shaheen
    Hanadi Alhozali
    Alferdose Osama Hariri
    Riyadh Ghazi Ahmad
    Moayad Reda Kabli
    Harold G. Koenig
    International Urology and Nephrology, 2014, 46 : 2393 - 2402
  • [36] The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis
    Araujoa, Ricardo
    Merino-Ribasa, Ana
    Pereiraa, Luciano
    Camposa, Joana
    Silva, Nadia
    Alencastrea, Ines Soares
    Pestanaa, Manuel
    Sampaio-Maia, Benedita
    NEFROLOGIA, 2024, 44 (02): : 194 - 203
  • [37] Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis
    Tan, Xiao
    Cao, Xuesen
    Zou, Jianzhou
    Shen, Bo
    Zhang, Xiaoyan
    Liu, Zhonghua
    Lv, Wenlv
    Teng, Jie
    Ding, Xiaoqiang
    HEMODIALYSIS INTERNATIONAL, 2017, 21 (02) : 161 - 167
  • [38] Bisphenol A analogs in patients with chronic kidney disease and dialysis therapy
    Shen, Yue
    Liu, Tingyan
    Shi, Yuanyuan
    Zhuang, Feng
    Lu, Jianxin
    Zhu, Qiuyu
    Ding, Feng
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2019, 185
  • [39] Assessment of nutritional status in children with chronic kidney disease and on dialysis
    Antonio Mastrangelo
    Fabio Paglialonga
    Alberto Edefonti
    Pediatric Nephrology, 2014, 29 : 1349 - 1358
  • [40] Paricalcitol for pre-dialysis stages of chronic kidney disease
    Almirall, Jaume
    Isabel Bolos, M.
    NEFROLOGIA, 2012, 32 (02): : 250 - 251